All News
Filter News
Found 808,890 articles
-
Small Bone Phantom 3-Hole Intramedullary Nail Added to Already Robust Offering for the Lapidus Arthrodesis Procedure
3/12/2019
Since its inception, Paragon 28® has obsessed over every aspect of foot and ankle surgery. Committed to creating tailored solutions to improve surgical outcomes, Paragon 28® has launched innovative products and instrumentation that help to streamline procedures, allow surgeons flexibility in technique and approach, and facilitate reproducible results benefiting both the surgeon and patient.
-
FDA Approves Dupixent® (dupilumab) for Moderate-to-severe Atopic Dermatitis in Adolescents - March 12, 2019
3/12/2019
Only therapy that targets the IL-4/IL-13 pathway, a key driver of the allergic or type 2 inflammation that underlies atopic dermatitis In a Phase 3 trial, Dupixent significantly reduced the extent and severity of disease and itching, and helped adolescents achieve clearer skin [12-March-2019] TARRYTOWN, N.Y. and CAMBRIDGE, Mass. , March 12, 2019 /PRNewswir
-
Vertex Receives Approval for SYMDEKO® (tezacaftor/ivacaftor and ivacaftor) in Australia, to Treat the Underlying Cause of Cystic Fibrosis in People aged 12 and Older with Certain CFTR Gene Mutations
3/12/2019
First medicine in Australia to treat the underlying cause of cystic fibrosis in patients who have certain mutations that result in residual CFTR function
-
Ligand to Participate in Four Upcoming Investor Conferences
3/12/2019
Ligand Pharmaceuticals Incorporated announces that company executives are scheduled to participate in the following upcoming investor conferences
-
Promethera Biosciences to Attend and Present at Upcoming Scientific and Partnering Conferences in March and April
3/12/2019
Promethera Biosciences SA announced that the Company will give presentations and attend the following scientific and partnering conferences in Japan, Europe, and the US.
-
Institute for Family Services: Groundbreaking New Book Offers a Roadmap to Healing Amidst Colonial and Historical Injustices
3/12/2019
"Dr. Rhea Almeida creates an entirely new paradigm, one in which there is deep trust in the human capacity to relate, collaborate, share, and heal." Jacqueline Battalora, Saint Xavier University, Author: Birth of a White Nation
-
Media Advisory - Canadian Food Inspection Agency (CFIA)
3/12/2019
The CFIA wishes to correct a news storyv issued earlier under the headline, "Amid swine fever outbreak, Canada bans Chinese pork imports
-
Biedermann Motech To Add Two Advanced Upper Extremity Solutions To Its Fracture Fixation Product Portfolio
3/12/2019
Biedermann Motech, the leader in polyaxial screw innovation for spine and extremities, today announced the further expansion of its product portfolio of advanced fracture fixation solutions.
-
My Special Aflac Duck Wins Big at SXSW
3/12/2019
Innovative Robotic Duck Takes Top Honors in the People's Choice and the Robotics and Hardware Categories at Premier Conference Celebrating the Convergence of the Interactive, Film and Music Industries
-
ERS Genomics Provides Comment on Issuance of University of California CRISPR/Cas9 Patent Including Uses of CRISPR ‘in a cell’
3/12/2019
U.S. Patent No. 10,227,611 issued to Dr. Emmanuelle Charpentier, University of California and University of Vienna
-
Akebia Therapeutics Announces Positive Top-Line Results from Two Pivotal Phase 3 Studies of Vadadustat in Japanese Patients with Anemia Due to Chronic Kidney Disease
3/12/2019
Akebia Therapeutics, Inc. announced positive top-line results from two phase 3 active-controlled pivotal studies evaluating vadadustat, an investigational oral hypoxia-inducible factor prolyl hydroxylase inhibitor (HIF-PHI), in Japanese subjects with anemia due to chronic kidney disease (CKD).
-
The Nutrition Facts Label and MyPlate Can Help You Make Healthier Food Choices
3/12/2019
The Food and Drug Administration's Nutrition Facts label and the U.S. Department of Agriculture's MyPlate can help.
-
American Board of Medical Specialties Announces Plan To Implement Recommendations From The Continuing Board Certification: Vision for the Future Commission
3/12/2019
ABMS to take immediate action on independent Commission's recommendations to make continuing certification programs more meaningful, relevant and of value to key stakeholders
-
Carbyne Partners With RapidSOS to Deliver Enhanced Emergency Response Capabilities to First Responders in the U.S.
3/12/2019
Carbyne is incorporating rich public safety data delivered from the RapidSOS Clearinghouse into Carbyne's industry-leading NG911 incident response solutions to shorten 9-1-1 call and dispatch times
-
xCures to Implement an Intermediate Size Expanded Access Protocol for ONC201 in H3 K27M-mutant Gliomas
3/12/2019
xCures and Cancer Commons are pleased to announce a collaboration with Oncoceutics to implement an Expanded Access program for ONC201.
-
CONMED Corporation Announces Annual Meeting of Shareholders
3/12/2019
CONMED Corporation announced that its Annual Meeting of Shareholders will be held at the Company’s corporate offices, 525 French Road, Utica, NY on Wednesday, May 22, 2019, at 3:30 p.m. ET.
-
Geisinger fully integrates OBERD's suite of products into EPIC
3/12/2019
Geisinger and OBERD have jointly developed bidirectional data integration tools for OBERD into EPIC using standard EPIC interfaces.
-
Tecentriq is a monoclonal antibody that binds with the PD-L1 protein expressed on tumor cells and tumor-infiltrating immune cells. It blocks interactions with both PD-1 and B7.1 receptors.
-
The company’s proprietary CRISPR-Cas tech platform is used to selectively and precisely eradicate target bacterial, but still leave the patient’s microbial community alone.
-
The next couple of weeks look to be busy for the FDA, with a string of target action dates scheduled. This week marks three scheduled approvals, two for extra indications for already-approved biologics, and the third for a combination treatment for glaucoma. Here’s a look.